At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling translational and clinical human ...

The PromethION-24 from ONT provides unparalleled flexibility in performing long-read sequencing across a wide range of sample types. By allowing up to 24 independent, simultaneous flow cell sequencing ...

Oxford Nanopore Technologies is looking forward to “the year of the proteome,” as co-founder and CEO Gordon Sanghera, PhD, labeled 2025 during his presentation at the recent 43rd Annual J.P. Morgan ...